Delivery Order SPE2DB25D3109-SPE2DB25FPKWW
- Not listed
- The Defense Logistics Agency awarded a $1,421.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Arimidex 1 mg, with an ultimate completion date of July 30, 2025. This non-set-aside contract was competitively awarded on July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this...
- The Defense Logistics Agency awarded a delivery order valued at $5,853.04 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count) with a firm fixed price arrangement. The contract, awarded on August 4, 2025, represents a non-set-aside competitive procurement with an ultimate completion date of August 5, 2025. Performance will be executed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a $3,034.37 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Arimidex 1 mg on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed price contract represents a non-competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The place of performance is...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,690.72, is for the delivery of 4,568,092,832 tablets of the prescription medication Arimidex (1 mg). The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $45,925.36 contract is for the delivery of 4,567,937,962 units of the pharmaceutical product Arimidex 1 mg tablets. The contract has an ultimate completion date of April 17, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a $22,432.41 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of ARIMIDEX 1 MG TABLET 30S, a pharmaceutical product, with a performance period through July 7, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, particularly the DLA. The company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,802.19 firm fixed-price delivery order is for the supply of ARIMIDEX 1 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $4,802.19 and an ultimate completion date of November 9, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ARIMIDEX 1 MG TABLET 30S, with a ceiling value of $4,235.26 and an ultimate completion date of January 28, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,981.82 fixed-price contract is for the delivery of 90-count bottles of the generic drug Anastrozole 1 mg Tablets. The contract has a period of performance through March 28, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Anastrozole 1 mg tablets. The $4,266.59 firm fixed-price contract has a performance period ending on September 2, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a broad range of pharmaceutical products...
- SPE2DB25D3109Indefinite Delivery Contract
- SPE2DB25D3109-SPE2DB25FPKWWDelivery Order
The Defense Logistics Agency awarded a $6,908.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Arimidex 1 mg, with an ultimate completion date of August 4, 2025. This non-set-aside contract was competitively awarded and is to be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger contract vehicle with the agency. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a wide range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and regularly fulfills delivery orders across multiple therapeutic domains for military and veteran healthcare systems through this flexible contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 8/1/25 |